TY - JOUR A1 - Kippenberger, Stefan A1 - Müller, Jutta A1 - Schultz, Maike A1 - Dorn, Annette A1 - Bock, Andreas A1 - Aygün, Hüseyin A1 - Thaçi, Diamant A1 - Hofmann, Matthias A1 - Kaufmann, Roland A1 - Bernd, August T1 - Oligonucleotides suppress PKB/Akt and act as superinductors of apoptosis in human keratinocytes T2 - Nucleic acids research N2 - DNA oligonucleotides (ODN) applied to an organism are known to modulate the innate and adaptive immune system. Previous studies showed that a CpG-containing ODN (CpG-1-PTO) and interestingly, also a non-CpG-containing ODN (nCpG- 5-PTO) suppress inflammatory markers in skin. In the present study it was investigated whether these molecules also influence cell apoptosis. Here we show that CpG-1-PTO, nCpG-5-PTO, and also natural DNA suppress the phosphorylation of PKB/Akt in a cell-type-specific manner. Interestingly, only epithelial cells of the skin (normal human keratinocytes, HaCaT and A-431) show a suppression of PKB/Akt. This suppressive effect depends from ODN lengths, sequence and backbone. Moreover, it was found that TGFa-induced levels of PKB/Akt and EGFR were suppressed by the ODN tested. We hypothesize that this suppression might facilitate programmed cell death. By testing this hypothesis we found an increase of apoptosis markers (caspase 3/7, 8, 9, cytosolic cytochrome c, histone associated DNA fragments, apoptotic bodies) when cells were treated with ODN in combination with low doses of staurosporin, a wellknown pro-apoptotic stimulus. In summary the present data demonstrate DNA as a modulator of apoptosis which specifically targets skin epithelial cells. Y1 - 2009 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/6599 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30-66889 SN - 1362-4962 SN - 0305-1048 N1 - © 2009 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. VL - 37 IS - 12 SP - 3850 EP - 3864 PB - Oxford Univ. Press CY - Oxford ER -